QPHENZI
Live / Applied — Second extension granted (statement of use) (as of 16 Dec 2025)
What this means for you
Not registered yet, but its 12 Jan 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98355310
- Mark type
- Stylized text
- Filed
- 12 Jan 2024
- Published for opposition
- 10 Dec 2024
- Attorney of record
- MICHELLE TOCHTROP
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of hypotension; pharmaceutical preparation in the nature of vasopressors for treatment of shock to raise blood pressure; pharmaceutical injectable preparations for increasing systolic blood pressure, diastolic blood pressure, mean arterial pressure and total peripheral vascular resistance; decongestant and vasoconstrictor preparation; phenylephrine pharmaceutical injectable preparation for use as a decongestant and vasoconstrictor
Owner
- HIKMA PHARMACEUTICALS USA INC., BERKELEY HEIGHTS, NJ, US
- Xellia Pharmaceuticals ApS, Copenhagen S, DK
- Xellia Pharmaceuticals ApS, Copenhagen S, DK
Prosecution history
- 17 Dec 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 16 Dec 2025 — SOU EXTENSION 2 GRANTED
- 16 Dec 2025 — SOU EXTENSION 2 FILED
- 16 Dec 2025 — SOU TEAS EXTENSION RECEIVED
- 15 Jul 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 14 Jul 2025 — SOU EXTENSION 1 GRANTED
- 14 Jul 2025 — SOU EXTENSION 1 FILED
- 14 Jul 2025 — SOU TEAS EXTENSION RECEIVED
- 12 Feb 2025 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 04 Feb 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 10 Dec 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 10 Dec 2024 — PUBLISHED FOR OPPOSITION
- 04 Dec 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 15 Nov 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 15 Nov 2024 — EXAMINER'S AMENDMENT ENTERED